Literature DB >> 26546081

Down-regulation of FBP1 by ZEB1-mediated repression confers to growth and invasion in lung cancer cells.

Juan Zhang1, Jiangtao Wang1, Hui Xing1, Qingfeng Li2, Qianfeng Zhao1, Jing Li1.   

Abstract

Lung cancer is the most common type of malignant tumor, but the molecular mechanisms for lung cancer progression remains to be elusive. Here, we demonstrated that FBP1 (Fructose-1, 6-bisphosphatase) was frequently down-regulated in lung cancer tissues and cells, and FBP1 down-regulation was associated with poor prognosis in lung cancer patients. Restored FBP1 expression inhibited glucose uptake and lactate production, but induced oxygen consumption. Restored FBP1 expression also inhibited lung cancer cells proliferation and invasion under hypoxia in vitro, and inhibited lung cancer growth in vivo. Moreover, we confirmed DNA methylation in the promoter contributed to the decrease of FBP1 expression in lung cancer cells. We identified Zinc finger E-box-binding homeobox 1 (ZEB1) bond to FBP1 promoter to enhance DNA methylation in lung cancer cells. Our findings indicate that the down-regulation of FBP1 is a critical oncogenic event in lung cancer progression.

Entities:  

Keywords:  FBP1; Invasion; Lung cancer; Proliferation; ZEB1

Mesh:

Substances:

Year:  2015        PMID: 26546081     DOI: 10.1007/s11010-015-2595-8

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  19 in total

1.  Defective binding of transcriptional repressor ZEB via DNA methylation contributes to increased constitutive levels of p73 in Fanconi anemia cells.

Authors:  Carlos Pipaon; Pedro J Real; Jose L Fernandez-Luna
Journal:  FEBS Lett       Date:  2005-08-29       Impact factor: 4.124

2.  Glucose controls nuclear accumulation, promoter binding, and transcriptional activity of the MondoA-Mlx heterodimer.

Authors:  Christopher W Peterson; Carrie A Stoltzman; Michael P Sighinolfi; Kyoung-Sim Han; Donald E Ayer
Journal:  Mol Cell Biol       Date:  2010-04-12       Impact factor: 4.272

3.  Glucose-dependent transcriptional regulation by an evolutionarily conserved glucose-sensing module.

Authors:  Ming V Li; Benny Chang; Minako Imamura; Naravat Poungvarin; Lawrence Chan
Journal:  Diabetes       Date:  2006-05       Impact factor: 9.461

Review 4.  Advances in chemotherapy in advanced non-small-cell lung cancer.

Authors:  Paolo Maione; Antonio Rossi; Paola Claudia Sacco; Maria Anna Bareschino; Clorinda Schettino; Cesare Gridelli
Journal:  Expert Opin Pharmacother       Date:  2010-08-12       Impact factor: 3.889

Review 5.  Otto Warburg's contributions to current concepts of cancer metabolism.

Authors:  Willem H Koppenol; Patricia L Bounds; Chi V Dang
Journal:  Nat Rev Cancer       Date:  2011-04-14       Impact factor: 60.716

6.  Loss of FBP1 by Snail-mediated repression provides metabolic advantages in basal-like breast cancer.

Authors:  Chenfang Dong; Tingting Yuan; Yadi Wu; Yifan Wang; Teresa W M Fan; Sumitra Miriyala; Yiwei Lin; Jun Yao; Jian Shi; Tiebang Kang; Pawel Lorkiewicz; Daret St Clair; Mien-Chie Hung; B Mark Evers; Binhua P Zhou
Journal:  Cancer Cell       Date:  2013-02-28       Impact factor: 31.743

7.  Warburg effect revisited: an epigenetic link between glycolysis and gastric carcinogenesis.

Authors:  X Liu; X Wang; J Zhang; E K Y Lam; V Y Shin; A S L Cheng; J Yu; F K L Chan; J J Y Sung; H C Jin
Journal:  Oncogene       Date:  2009-11-02       Impact factor: 9.867

Review 8.  E-cadherin, beta-catenin, and ZEB1 in malignant progression of cancer.

Authors:  Otto Schmalhofer; Simone Brabletz; Thomas Brabletz
Journal:  Cancer Metastasis Rev       Date:  2009-06       Impact factor: 9.264

Review 9.  Hallmarks of cancer: the next generation.

Authors:  Douglas Hanahan; Robert A Weinberg
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

10.  Promoter hypermethylation mediated downregulation of FBP1 in human hepatocellular carcinoma and colon cancer.

Authors:  Mingquan Chen; Jianbin Zhang; Ning Li; Zhiping Qian; Mengqi Zhu; Qian Li; Jianming Zheng; Xinyu Wang; Guangfeng Shi
Journal:  PLoS One       Date:  2011-10-19       Impact factor: 3.240

View more
  29 in total

1.  The lncRNA MIR4435-2HG promotes lung cancer progression by activating β-catenin signalling.

Authors:  Haiyun Qian; Li Chen; Jiangping Huang; Xianghui Wang; Shengwei Ma; Fenghe Cui; Liyun Luo; Li Ling; Kai Luo; Guopei Zheng
Journal:  J Mol Med (Berl)       Date:  2018-06-05       Impact factor: 4.599

Review 2.  Gluconeogenesis in cancer cells - Repurposing of a starvation-induced metabolic pathway?

Authors:  Gabriele Grasmann; Elisabeth Smolle; Horst Olschewski; Katharina Leithner
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2019-05-30       Impact factor: 10.680

3.  The involvement of FBP1 in prostate cancer cell epithelial mesenchymal transition, invasion and metastasis by regulating the MAPK signaling pathway.

Authors:  Yan-Ping Zhang; Kai-Long Liu; Zhan Yang; Bao-Sai Lu; Jin-Chun Qi; Zhen-Wei Han; Yue-Wei Yin; Ming Zhang; De-Min Chen; Xiao-Wei Wang; Wei Li; Hong Xin
Journal:  Cell Cycle       Date:  2019-08-25       Impact factor: 4.534

4.  Loss of fructose-1,6-bisphosphatase induces glycolysis and promotes apoptosis resistance of cancer stem-like cells: an important role in hexavalent chromium-induced carcinogenesis.

Authors:  Jin Dai; Yanli Ji; Wei Wang; Donghern Kim; Leonard Yenwong Fai; Lei Wang; Jia Luo; Zhuo Zhang
Journal:  Toxicol Appl Pharmacol       Date:  2017-06-15       Impact factor: 4.219

Review 5.  Proteins moonlighting in tumor metabolism and epigenetics.

Authors:  Lei Lv; Qunying Lei
Journal:  Front Med       Date:  2021-01-02       Impact factor: 4.592

6.  Oxidative Stress and Metabolic Reprogramming in Cr(VI) Carcinogenesis.

Authors:  Marco Clementino; Xianglin Shi; Zhuo Zhang
Journal:  Curr Opin Toxicol       Date:  2017-12-05

7.  Fructose-1,6-bisphosphatase Inhibits ERK Activation and Bypasses Gemcitabine Resistance in Pancreatic Cancer by Blocking IQGAP1-MAPK Interaction.

Authors:  Xin Jin; Yunqian Pan; Liguo Wang; Tao Ma; Lizhi Zhang; Amy H Tang; Daniel D Billadeau; Heshui Wu; Haojie Huang
Journal:  Cancer Res       Date:  2017-07-18       Impact factor: 12.701

8.  Increased miR-21a provides metabolic advantages through suppression of FBP1 expression in non-small cell lung cancer cells.

Authors:  Qingchun Dai; Na Li; Xiaohong Zhou
Journal:  Am J Cancer Res       Date:  2017-11-01       Impact factor: 6.166

9.  Culturing conditions highly affect DNA methylation and gene expression levels in MCF7 breast cancer cell line.

Authors:  Lama Hamadneh; May Al-Majawleh; Yazun Jarrar; Sawsan Shraim; Mariam Hasan; Basha'er Abu-Irmaileh
Journal:  In Vitro Cell Dev Biol Anim       Date:  2018-04-09       Impact factor: 2.416

Review 10.  Research advances on epigenetics and cancer metabolism.

Authors:  Hengyi Han; Fan Feng; Haitao Li
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2021-02-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.